The frequencies of circulating IgG4+ peripheral blood B cells (IgG4+CD45+CD22+CD19+CD3−CD14−) in melanoma patients with melanoma compared to those from healthy volunteers were determined by flow cytometric analyses (Fig. 3A). This evidence concerns the gene CD19 and melanoma.